Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
7,790 JPY | -1.52% | +7.01% | -25.53% |
Strengths
- Its core activity has a significant growth potential and sales are expected to surge, according to Standard & Poor's' forecast. Indeed, those may increase by 57% by 2026.
- The company's profit outlook over the next few years is a strong asset.
- Over the last twelve months, the sales forecast has been frequently revised upwards.
- Sales forecast by analysts have been recently revised upwards.
- The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
- Consensus analysts have strongly revised their opinion of the company over the past 12 months.
- Analysts' price targets are all relatively close, reflecting good visibility on the company's valuation.
- Historically, the company has been releasing figures that are above expectations.
Weaknesses
- The company's valuation in terms of earnings multiples is rather high. Indeed, the firm is getting paid 68.87 times its estimated earnings per share for the ongoing year.
- The company appears highly valued given the size of its balance sheet.
- The valuation of the company is particularly high given the cash flows generated by its activity.
- The company is not the most generous with respect to shareholders' compensation.
Ratings chart - Surperformance
Sector: Business Support Services
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-25.53% | 423M | - | ||
+16.61% | 90.5B | B | ||
+4.04% | 67.42B | B | ||
-7.07% | 45.17B | C- | ||
-12.46% | 28.48B | C- | ||
+0.96% | 20.35B | C+ | ||
-13.10% | 12.46B | A- | ||
-8.92% | 10.14B | C | ||
+6.58% | 8.73B | C+ | ||
-15.66% | 8.57B | B+ |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- 4051 Stock
- Ratings GMO Financial Gate, Inc.